{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,1,5]],"date-time":"2025-01-05T08:40:35Z","timestamp":1736066435752,"version":"3.32.0"},"reference-count":15,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2004,5,1]],"date-time":"2004-05-01T00:00:00Z","timestamp":1083369600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2004,5,1]],"date-time":"2004-05-01T00:00:00Z","timestamp":1083369600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ard.eular.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of the Rheumatic Diseases"],"published-print":{"date-parts":[[2004,5]]},"DOI":"10.1136\/ard.2003.012302","type":"journal-article","created":{"date-parts":[[2004,4,13]],"date-time":"2004-04-13T17:33:15Z","timestamp":1081877595000},"page":"489-493","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Tumour necrosis factor \u03b1 independent disease mechanisms in rheumatoid arthritis: a histopathological study on the effect of infliximab on rheumatoid nodules"],"prefix":"10.1016","volume":"63","author":[{"given":"D","family":"Baeten","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F","family":"De Keyser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E M","family":"Veys","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y","family":"Theate","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F A","family":"Houssiau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P","family":"Durez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1136\/ard.2003.012302_bib1","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1136\/ard.52.9.625","article-title":"Rheumatoid nodules: differential diagnosis and immunohistological findings","volume":"52","author":"Veys","year":"1993","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2003.012302_bib2","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1136\/ard.52.11.801","article-title":"Palisading cells of rheumatoid nodules: comparison with synovial intimal cells","volume":"52","author":"Edwards","year":"1993","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2003.012302_bib3","first-page":"867","article-title":"Accelerated nodulosis during low dose MTX therapy for rheumatoid arthritis: an analysis of ten cases","volume":"19","author":"Kerstens","year":"1992","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.2003.012302_bib4","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1002\/art.10082","article-title":"Effect of etanercept on tenosynovitis and nodules in rheumatoid arthritis","volume":"46","author":"Kaiser","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2003.012302_bib5","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1002\/art.10535","article-title":"Accelerated nodulosis and vacsulitis following etanercept therapy for rheumatoid arthritis","volume":"47","author":"Cunnane","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2003.012302_bib6","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1002\/art.10096","article-title":"Development of rheumatoid nodules during anti-tumor necrosis factor alpha therapy with etanercept","volume":"46","author":"Kekow","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2003.012302_bib7","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1002\/1529-0131(200101)44:1<186::AID-ANR25>3.0.CO;2-B","article-title":"Immunomodulatory effects of anti-TNF-\u03b1 therapy on synovium in spondyloarthropathy: histologic findings in eight patients from an open-label pilot study","volume":"44","author":"Baeten","year":"2001","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2003.012302_bib8","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1136\/ard.57.8.480","article-title":"A comparative phenotypical analysis of rheumatoid nodules and rheumatoid synovium with special reference to adhesion molecules and activation markers","volume":"57","author":"Elewaut","year":"1998","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2003.012302_bib9","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1002\/1529-0131(199810)41:10<1783::AID-ART10>3.0.CO;2-W","article-title":"Pathogenic mechanisms in the rheumatoid nodule: comparison of proinflammatory cytokine production and cell adhesion molecule expression in rheumatoid nodules and synovial membranes from the same patients","volume":"41","author":"Wikaningrum","year":"1998","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2003.012302_bib10","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1002\/art.1780390702","article-title":"Decrease in cellularity and expression of adhesion molecules by anti-tumor necrosis factor \u03b1 monocloncal antibody treatment in patients with rheumatoid arthritis","volume":"39","author":"Tak","year":"1996","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2003.012302_bib11","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1056\/NEJMoa011110","article-title":"Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent","volume":"345","author":"Keane","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1136\/ard.2003.012302_bib12","first-page":"1308","article-title":"Adenosine A1 receptor promotion of multinucleated giant cell formation by human monocytes: a mechanism for methotrexate-induced nodulosis in rheumatoid arthritis","volume":"40","author":"Merrill","year":"1997","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2003.012302_bib13","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1093\/rheumatology\/37.2.126","article-title":"Rheumatoid arthritis: the predictable effect of small immune complexes in which antibody is also antigen","volume":"37","author":"Edwards","year":"1998","journal-title":"Br J Rheumatol"},{"key":"10.1136\/ard.2003.012302_bib14","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1046\/j.1365-2249.1997.3941286.x","article-title":"Restricted expression of Fc\u03b3RIII (CD16) in synovium and dermis: implications for tissue targeting in rheumatoid arthritis","volume":"108","author":"Edwards","year":"1997","journal-title":"Clin Exp Immunol"},{"key":"10.1136\/ard.2003.012302_bib15","first-page":"28","article-title":"Fc\u03b3 receptor type IIIA is associated with rheumatoid arthritis in two distinct ethnic groups","volume":"23","author":"Morgan","year":"2000","journal-title":"Arthritis Rheum"}],"container-title":["Annals of the Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000349672408289X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000349672408289X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ard.2003.012302","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,5]],"date-time":"2025-01-05T08:13:39Z","timestamp":1736064819000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000349672408289X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,5]]},"references-count":15,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2004,5]]}},"alternative-id":["S000349672408289X"],"URL":"https:\/\/doi.org\/10.1136\/ard.2003.012302","relation":{},"ISSN":["0003-4967"],"issn-type":[{"type":"print","value":"0003-4967"}],"subject":[],"published":{"date-parts":[[2004,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tumour necrosis factor \u03b1 independent disease mechanisms in rheumatoid arthritis: a histopathological study on the effect of infliximab on rheumatoid nodules","name":"articletitle","label":"Article Title"},{"value":"Annals of the Rheumatic Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/ard.2003.012302","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2004 Copyright 2004 by Annals of the Rheumatic Diseases, Published by Elsevier Inc. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}